|Mr. Mark G. Thompson||Chief Financial Officer and Sec.||97.49k||N/A||55|
|Mr. Jonathan M. Couchman CFA||Chief Exec. Officer, Pres and Director||N/A||N/A||47|
|Dr. Tracy J. Dunn Ph.D., J.D.||VP of Intellectual Property & Legal Affairs||N/A||N/A||54|
|Ms. Kay Slocum||Sr. VP of HR||N/A||N/A||70|
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Affymax, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.